Literature DB >> 21129335

Contribution of an intrinsic lag of continuous glucose monitoring systems to differences in measured and actual glucose concentrations changing at variable rates in vitro.

Raymond J Davey1, Chee Low, Timothy W Jones, Paul A Fournier.   

Abstract

BACKGROUND: Current continuous glucose monitoring (CGM) systems measure glucose levels in the interstitial fluid to estimate blood glucose concentration. A lag time has been observed between CGM system glucose readings and blood glucose levels when glucose levels are changing. Although this lag has been attributed to the time it takes glucose to equilibrate between blood and interstitial fluid compartments, it is unclear to what extent these inaccuracies reflect an intrinsic delay of the device itself.
METHODS: Four Guardian® REAL-Time CGM systems (CGMSs) (Medtronic Diabetes, Minimed, CA) and eight glucose sensors were tested in glucose solutions prepared in Krebs bicarbonate buffers at 37 °C. Glucose readings obtained from CGMSs were compared with actual glucose concentrations during controlled changes in glucose concentration performed at four rates (30, 90, and 220 mg/dl/hr(-1) and an instantaneous change of 110 mg/dl) using a linear gradient maker.
RESULTS: Irrespective of the rate and direction of changes in glucose concentration, the readings obtained from CGMSs were significantly different from actual glucose levels. The faster the rise or fall in actual glucose concentration, the more pronounced the mismatch with CGMS glucose readings. Furthermore, the intrinsic lag times (8.3 to 40.1 min) were high enough to account for the lags reported in previous in vivo studies.
CONCLUSIONS: The lag intrinsic of the CGMS may make a significant contribution to the mismatch between CGM system readings and blood glucose concentrations.
© 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129335      PMCID: PMC3005050          DOI: 10.1177/193229681000400614

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  30 in total

1.  The MiniMed continuous glucose monitoring system.

Authors:  J J Mastrototaro
Journal:  Diabetes Technol Ther       Date:  2000       Impact factor: 6.118

2.  Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?

Authors:  Teresa P Monsod; Daniel E Flanagan; Fran Rife; Rebecca Saenz; Sonia Caprio; Robert S Sherwin; William V Tamborlane
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

3.  Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia.

Authors:  N J Caplin; P O'Leary; M Bulsara; E A Davis; T W Jones
Journal:  Diabet Med       Date:  2003-03       Impact factor: 4.359

4.  Prevention of hypoglycemia using risk assessment with a continuous glucose monitoring system.

Authors:  Carine Choleau; Petr Dokladal; Jean-Claude Klein; W Kenneth Ward; George S Wilson; Gérard Reach
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

5.  A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose.

Authors:  J L Parkes; S L Slatin; S Pardo; B H Ginsberg
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

6.  Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor.

Authors:  Garry M Steil; Kerstin Rebrin; John Mastrototaro; Basem Bernaba; Mohammed F Saad
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

7.  Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements.

Authors:  Richard L Weinstein; Sherwyn L Schwartz; Ronald L Brazg; Jolyon R Bugler; Thomas A Peyser; Geoffrey V McGarraugh
Journal:  Diabetes Care       Date:  2007-03-02       Impact factor: 19.112

8.  Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.

Authors:  J A Tamada; S Garg; L Jovanovic; K R Pitzer; S Fermi; R O Potts
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

9.  Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring.

Authors:  B Aussedat; M Dupire-Angel; R Gifford; J C Klein; G S Wilson; G Reach
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-04       Impact factor: 4.310

10.  Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels.

Authors:  S N Thennadil; J L Rennert; B J Wenzel; K H Hazen; T L Ruchti; M B Block
Journal:  Diabetes Technol Ther       Date:  2001       Impact factor: 6.118

View more
  17 in total

1.  Do different glucose levels at calibration influence accuracy of continuous glucose monitoring readings in vitro?

Authors:  Katherine E Iscoe; Raymond J Davey; Paul A Fournier
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  Accuracy performance of the Medtronic NexSensor™ for 6 days in an inpatient setting using abdomen and buttocks insertion sites.

Authors:  Tim Peoples; Timothy Bailey; Brazg Ronald; Howard C Zisser; Bob Janowski; Suiying Huang; Cary Talbot; Qingqing Yang
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

3.  Discrepancies Between Blood Glucose and Interstitial Glucose-Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic Target.

Authors:  Thorsten Siegmund; Lutz Heinemann; Ralf Kolassa; Andreas Thomas
Journal:  J Diabetes Sci Technol       Date:  2017-03-21

4.  Pilot study of a prototype minimally invasive intradermal continuous glucose monitor.

Authors:  Ruth S Weinstock; Suzan Bristol; Andrew Armenia; A Chris Gesswein; B Wayne Bequette; John P Willis
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

5.  Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems.

Authors:  Cosimo Scuffi
Journal:  Eur Endocrinol       Date:  2014-02-28

6.  Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.

Authors:  Firas H El-Khatib; Steven J Russell; Kendra L Magyar; Manasi Sinha; Katherine McKeon; David M Nathan; Edward R Damiano
Journal:  J Clin Endocrinol Metab       Date:  2014-01-31       Impact factor: 5.958

7.  Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.

Authors:  Dessi P Zaharieva; Kamuran Turksoy; Sarah M McGaugh; Rubin Pooni; Todd Vienneau; Trang Ly; Michael C Riddell
Journal:  Diabetes Technol Ther       Date:  2019-05-06       Impact factor: 6.118

8.  Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.

Authors:  Erwan Leclair; Richard T Liggins; Ashley J Peckett; Trevor Teich; David H Coy; Mladen Vranic; Michael C Riddell
Journal:  Diabetologia       Date:  2016-04-13       Impact factor: 10.122

9.  Increasing the low-glucose alarm of a continuous glucose monitoring system prevents exercise-induced hypoglycemia without triggering any false alarms.

Authors:  Katherine E Iscoe; Raymond J Davey; Paul A Fournier
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

10.  Modelling the relationship between continuously measured glucose and electrocardiographic data in adults with type 1 diabetes mellitus.

Authors:  Beatrice Charamba; Aaron Liew; Eileen Coen; John Newell; Timothy O'Brien; William Wijns; Andrew J Simpkin
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.